サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519444

バイオインフォマティクス市場レポート：製品・サービス、用途、最終用途分野、地域別、2024～2032年

Bioinformatics Market Report by Product and Service, Application, End-Use Sector, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 137 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
バイオインフォマティクス市場レポート：製品・サービス、用途、最終用途分野、地域別、2024～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオインフォマティクス市場規模は2023年に123億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに362億米ドルに達し、2024～2032年の間に12.3％の成長率（CAGR）を示すと予測しています。急速な技術進歩、ゲノム解読の増加、個別化医療に対する需要の急増、データ解析の成長、研究開発（R&D）への投資、生物学的データベースの拡大、予防医療への注目の高まりなどは、市場成長を促進する要因の一部です。

バイオインフォマティクス市場分析：

市場の成長と規模バイオインフォマティクス市場は、医療、農業、環境バイオテクノロジーにおける重要な役割に後押しされ、大幅な成長を遂げています。この拡大は市場規模の拡大に反映されており、堅調な増加傾向が予測されています。この成長は、統合されたデータソリューションに対する需要の高まり、急増する生物学的データ量、様々な科学的領域におけるバイオインフォマティクスの広範な応用によって促進されています。バイオインフォマティクス市場調査が強調しているように、このセグメントは複雑な生物学的データセットの解読、個別化医療におけるイノベーションの推進、疾患の遺伝的・分子的基盤の理解強化において不可欠なものとなりつつあり、市場の拡大と進化に大きく寄与しています。

主要市場促進要因：主要市場促進要因としては、費用対効果の高さによる核酸・タンパク質シーケンシングの需要拡大、クラウドコンピューティングの統合、微生物ゲノムプロジェクトの増加などが挙げられます。さらに、データ統合と管理への重点の高まり、臨床診断と精密医療における広範な利用、バイオ医薬品産業の拡大、分子生物学の進歩、免疫ゲノミクスへの注目の高まりなどが市場成長を後押ししています。これとは別に、バイオインフォマティクス新興企業への投資強化や、計算と生物学研究を組み合わせた共同プロジェクトの急増が、総体的にバイオインフォマティクスの成長を後押しし、ダイナミックで急速に進化する状況を形成しています。

技術の進歩：技術の進歩は、複雑な生物学的データに対処するための継続的なイノベーションが鍵となるバイオインフォマティクス市場において、依然として極めて重要な力となっています。強化された計算能力、洗練されたアルゴリズム、機械学習（ML）アプリケーションは、ゲノムとプロテオミクス解析の進歩に役立っています。このような技術的進歩は、バイオインフォマティクスツールの能力を拡大するだけでなく、医療、農業、環境研究など、さまざまなセグメントでの応用範囲を広げています。このような進歩により、バイオインフォマティクスセグメントは科学研究の最前線にとどまることができ、生物学的データの迅速、正確、かつ費用対効果の高い分析を促進することができ、これはバイオインフォマティクス市場の動向に不可欠です。

産業への応用：バイオインフォマティクスの産業応用は、医療、製薬、農業、環境科学など多岐にわたります。医療では、個別化医療の開発や遺伝子疾患の理解に極めて重要です。製薬セグメントでは、創薬、薬剤開発、バイオマーカー同定にバイオインフォマティクスが活用されています。農業セグメントでは、作物の改良や家畜の管理に役立ち、環境科学セグメントでは、生物多様性の保全や生態系の健全性のモニタリングに利用されています。

主要市場動向：バイオインフォマティクス市場の特徴は、データ解析における人工知能（AI）とMLの利用の増加、ゲノムデータの解釈を必要とする個別化医療の台頭、臨床診断における応用の拡大、クラウドベースのバイオインフォマティクスソリューションの拡大です。さらに、ゲノムデータを活用した精密農業の重視、バイオマーカー探索の需要の急増、包括的解析のためのマルチオミクスデータの統合が、市場の成長を後押ししています。

地理的動向：バイオインフォマティクス市場では、北米が先進的な技術インフラ、研究開発への多額の投資、主要な業界参入企業の強力なプレゼンスによりリードしており、地理的な格差が顕著です。この地域の優位性は、次世代シーケンサー、高性能コンピューティングの急速な導入、医療や農業バイオテクノロジーにおけるバイオインフォマティクスの広範な利用に起因しています。欧州とアジア太平洋も注目すべき貢献者であり、欧州はその強固な研究枠組みから恩恵を受け、アジア太平洋はバイオベンチャーの増加と政府支援の増加により急成長を示しています。

競合情勢：競合情勢は非常にダイナミックで、既存企業と新興新興企業が混在しています。これらの企業は、イノベーション、技術力、戦略的提携で競争しています。市場リーダーは、複雑化する生物学的データ解析に対応する高度なソリューションを導入するため、継続的に研究開発に投資しています。また、このセグメントではM&Aも盛んに行われており、各社はオファリングの強化と市場範囲の拡大に努めています。

課題と機会：バイオインフォマティクス市場には、データの複雑性、専門スキルの必要性、データのプライバシーやセキュリティに関する問題など、課題が山積しています。しかし、これらの課題は、市場の成長とイノベーションのためのまたとない機会をもたらします。生物学的データの増加により、より洗練されたバイオインフォマティクス・ツールの開発が必要となり、AIや機械学習の進歩の機会が生まれます。さらに、個別化医療に対する需要の高まりと、様々な産業におけるバイオインフォマティクスの応用の拡大は、このセグメントに広大な展望をもたらします。

バイオインフォマティクス市場動向：

技術の進歩

技術の進歩はバイオインフォマティクス市場の基盤となる推進力であり、その成長と能力に大きな影響を与えています。計算アルゴリズム、高性能シーケンス技術、データ処理ソフトウエアの革新はバイオインフォマティクスに革命をもたらし、膨大な生物学的データセットをかつてないスピードと精度で解析することを可能にしました。これらの進歩により、複雑なゲノム解析やプロテオーム解析が容易になり、生物学的プロセスや疾病メカニズムの理解において大きなブレークスルーがもたらされました。また、より洗練されたバイオインフォマティクスツールの開発も可能になり、ゲノミクス、トランスクリプトミクス、その他さまざまなオミクスセグメントの研究効率を向上させることで、科学的発見や、個別化医療、創薬、その他のセグメントへの応用を加速させています。

ゲノム配列決定の増加

ゲノム配列決定の急増は、配列決定技術のコスト低下と利用しやすさの向上に後押しされた極めて重要な推進力です。シーケンシングが普及するにつれ、膨大な量のデータが生成されるため、効果的なデータ保存、管理、解析のための高度なバイオインフォマティクスツールが必要となります。このようなゲノムデータの急激な増加は、個別化医療を推進し、疾患に対する遺伝的素因を理解し、標的療法を開発する上で極めて重要です。ゲノムの塩基配列を迅速かつ安価に決定できるようになったことで、生物学研究は一変し、ヒト遺伝学、進化生物学、微生物ゲノミクスなどのより包括的な研究が可能になり、膨大なデータセットの複雑性を管理・解読するバイオインフォマティクスの限界に課題しています。

個別化医療に対する需要の急増

個別化医療への要求は、医療のカスタマイズ化を強調し、個々の患者に合わせた医療判断や治療を行うというバイオインフォマティクス市場を大きく形成しています。このアプローチは、ゲノムと臨床データを活用して、病気の分子基盤を理解し、特定の病気に対する感受性を予測し、個別化された治療レジメンを設計します。バイオインフォマティクスはこのプロセスに不可欠であり、健康や疾病に影響を与える遺伝的変異や分子パターンを分析・解釈する計算能力を記載しています。その結果得られる洞察により、医療プロバイダーはより多くの情報に基づいた決断を下し、的を絞った治療法を提供し、患者の転帰を改善することができます。

データ解析の成長

バイオインフォマティクスにおけるデータ解析の成長は変革的であり、ゲノム配列決定、遺伝子発現研究、その他のオーミック技術によって生成される複雑なデータを解読するための強力なツールを提供しています。バイオインフォマティクスは、ゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスといった複数のオミクスレベルからのデータを統合することにますます重点を置くようになっており、生物学的システムと疾患メカニズムのより包括的な理解を提供しています。さらに、バイオインフォマティクスにおけるデータ解析は、予測モデリング、パターン認識、データ解釈のための機械学習（ML）や人工知能（AI）技術に大きく依存しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブ概要

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオインフォマティクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 知識管理ツール
    • 市場動向
    • 主要タイプ
      • 汎用的な知識管理ツール
      • 専門的な知識管理ツール
    • 市場予測
  • バイオインフォマティクスプラットフォーム
    • 市場動向
    • 主要タイプ
      • 外科手術シミュレーションプラットフォーム
      • 配列解析、配列、操作プラットフォーム
      • 構造と機能解析プラットフォーム
      • その他
    • 市場予測
  • バイオインフォマティクスサービス
    • 市場動向
    • 主要タイプ
      • データ分析サービス
      • データベース管理サービス
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • ゲノミクス
  • ケモインフォマティクスと医薬品設計
  • プロテオミクス
  • トランスクリプトミクス
  • メタボロミクス
  • その他

第8章 市場内訳：用途別

  • 医療バイオテクノロジー
  • 学術
  • 動物バイオテクノロジー
  • 農業バイオテクノロジー
  • 環境バイオテクノロジー
  • 法医学バイオテクノロジー
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ABM Industries
    • Agilent Technologies
    • Biomax Informatics
    • Data4cure Inc.
    • Dnastar Inc.
    • Illumina Inc.
    • Life Technologies
    • Perkinelmer Inc.
    • Qiagen N.V.
    • Quest Diagnostics
    • Sophia Genetics SA
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
    • WuXi Nextcode Genomics
図表

List of Figures

  • Figure 1: Global: Bioinformatics Market: Major Drivers and Challenges
  • Figure 2: Global: Bioinformatics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bioinformatics Market: Breakup by Product and Service (in %), 2023
  • Figure 4: Global: Bioinformatics Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Bioinformatics Market: Breakup by End-Use Sector (in %), 2023
  • Figure 6: Global: Bioinformatics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Bioinformatics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Bioinformatics (Knowledge Management Tools) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Bioinformatics (Knowledge Management Tools) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Bioinformatics (Bioinformatics Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Bioinformatics (Bioinformatics Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Bioinformatics (Bioinformatics Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Bioinformatics (Bioinformatics Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Bioinformatics (Genomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Bioinformatics (Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Bioinformatics (Chemoinformatics and Drug Design) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Bioinformatics (Chemoinformatics and Drug Design) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Bioinformatics (Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Bioinformatics (Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Bioinformatics (Transcriptomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Bioinformatics (Transcriptomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Bioinformatics (Metabolomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Bioinformatics (Metabolomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Bioinformatics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Bioinformatics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Bioinformatics (Medical Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Bioinformatics (Medical Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Bioinformatics (Academics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Bioinformatics (Academics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Bioinformatics (Animal Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Bioinformatics (Animal Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Bioinformatics (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Bioinformatics (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Bioinformatics (Environmental Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Bioinformatics (Environmental Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Bioinformatics (Forensic Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Bioinformatics (Forensic Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Bioinformatics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Bioinformatics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia Pacific: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia Pacific: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Bioinformatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Bioinformatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Bioinformatics Industry: SWOT Analysis
  • Figure 89: Global: Bioinformatics Industry: Value Chain Analysis
  • Figure 90: Global: Bioinformatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioinformatics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bioinformatics Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Bioinformatics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Bioinformatics Market Forecast: Breakup by End-Use Sector (in Million US$), 2024-2032
  • Table 5: Global: Bioinformatics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Bioinformatics Market: Competitive Structure
  • Table 7: Global: Bioinformatics Market: Key Players
目次
Product Code: SR112024A2129

The global bioinformatics market size reached US$ 12.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 36.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032. Rapid technological advancements, increasing genomic sequencing, surging demand for personalized medicine, data analytics growth, investment in research and development (R&D), expanding biological databases, and the rising focus on preventive care are some of the factors fostering the market growth.

Bioinformatics Market Analysis:

Market Growth and Size: The bioinformatics market is witnessing substantial growth, propelled by its critical role in healthcare, agriculture, and environmental biotechnology. The expansion is reflected in the increasing market size, with projections indicating robust upward trends. This growth is fueled by the escalating demand for integrated data solutions, the burgeoning volume of biological data, and the widespread application of bioinformatics in various scientific domains. As bioinformatics market research underscores, this sector is becoming indispensable in deciphering complex biological datasets, driving innovations in personalized medicine, and enhancing our understanding of genetic and molecular foundations of diseases, thereby contributing significantly to the market's expansion and evolution.

Major Market Drivers: The major market drivers include the escalating demand for nucleic acid and protein sequencing due to its cost-effectiveness, the integration of cloud computing, and the rise in microbial genome projects. Moreover, the increasing emphasis on data integration and management, widespread utilization in clinical diagnostics and precision medicine, expansion in the biopharmaceutical industry, and advancements in molecular biology, rising focus on immunogenomics, which is boosting the market growth. Apart from this, enhanced investment in bioinformatics startups and the surge in collaborative projects combining computational and biological research, collectively fuel the bioinformatics market growth, shaping a dynamic and rapidly evolving landscape.

Technological Advancements: Technological advancements remain a pivotal force in the bioinformatics market, where ongoing innovation is key to addressing the complexity of biological data. Enhanced computational power, sophisticated algorithms, and machine learning (ML) applications are instrumental in advancing genomic and proteomic analyses. These technological strides are not only expanding the capabilities of bioinformatics tools but also are broadening their applicability across different sectors, including healthcare, agriculture, and environmental studies. Such advancements ensure that the bioinformatics field stays at the forefront of scientific research, facilitating rapid, accurate, and cost-effective analysis of biological data, which is essential for bioinformatics market trends.

Industry Applications: The industry applications of bioinformatics span across healthcare, pharmaceuticals, agriculture, and environmental sciences. In healthcare, it's pivotal for developing personalized medicine and understanding genetic disorders. The pharmaceutical sector relies on bioinformatics for drug discovery, development, and biomarker identification. In agriculture, it aids in crop improvement and livestock management, while in environmental science, it's used for biodiversity conservation and monitoring ecosystem health.

Key Market Trends: The bioinformatics market is characterized by the increasing use of artificial intelligence (AI) and ML in data analysis, the rise of personalized medicine requiring genomic data interpretation, the growing application in clinical diagnostics, and the expansion of cloud-based bioinformatics solutions. Moreover, the emphasis on precision agriculture leveraging genomic data, the surge in demand for biomarker discovery, and the integration of multi-omics data for comprehensive analysis are boosting the market growth.

Geographical Trends: The bioinformatics market exhibits significant geographical disparities, with North America leading due to its advanced technological infrastructure, substantial investments in R&D, and strong presence of key industry players. The region's dominance is attributed to its rapid adoption of next-generation sequencing, high-throughput computing, and extensive use of bioinformatics in healthcare and agricultural biotechnology. Europe and Asia-Pacific are also notable contributors, with Europe benefiting from its robust research framework and Asia-Pacific witnessing fast-paced growth due to rising biotechnology ventures and increasing governmental support.

Competitive Landscape: The competitive landscape of the bioinformatics market is intensely dynamic, featuring a mix of established companies and emerging startups. These entities compete on innovation, technological prowess, and strategic collaborations. Market leaders are continuously investing in R&D to introduce advanced solutions that cater to the growing complexity of biological data analysis. The sector is also witnessing a trend of mergers and acquisitions, as companies strive to enhance their offerings and expand their market reach.

Challenges and Opportunities: The bioinformatics market is laden with challenges, including data complexity, the need for specialized skills, and issues related to data privacy and security. However, these challenges present unique opportunities for market growth and innovation. The increasing volume of biological data necessitates the development of more sophisticated bioinformatics tools, creating opportunities for advancements in AI and machine learning. Moreover, the growing demand for personalized medicine and the expanding application of bioinformatics across various industries offer vast prospects for the sector.

Bioinformatics Market Trends:

Technological advancements

Technological advancements are a cornerstone driver of the bioinformatics market, profoundly impacting its growth and capabilities. Innovations in computational algorithms, high-throughput sequencing technologies, and enhanced data processing software have revolutionized bioinformatics, enabling the analysis of vast biological datasets at unprecedented speeds and accuracy. These advancements facilitate complex genomic and proteomic analyses, leading to significant breakthroughs in understanding biological processes and disease mechanisms. They also enable the development of more sophisticated bioinformatics tools, improving the efficiency of research in genomics, transcriptomics, and various other omics fields, thereby accelerating scientific discoveries and their applications in personalized medicine, drug discovery, and other areas.

Increased genomic sequencing

The surge in genomic sequencing is a pivotal driver, fueled by the declining costs and improved accessibility of sequencing technologies. As sequencing becomes more widespread, it generates enormous volumes of data, necessitating advanced bioinformatics tools for effective data storage, management, and analysis. This exponential increase in genomic data is crucial for advancing personalized medicine, understanding genetic predispositions to diseases, and developing targeted therapies. The ability to sequence genomes rapidly and affordably has transformed biological research, enabling more comprehensive studies of human genetics, evolutionary biology, and microbial genomics, thus pushing the boundaries of bioinformatics to manage and decipher the complexity of these vast datasets.

Surging demand for personalized medicine

The demand for personalized medicine is significantly shaping the bioinformatics market, emphasizing the customization of healthcare, with medical decisions and treatments tailored to individual patients. This approach leverages genomic and clinical data to understand the molecular basis of diseases, predict the susceptibility to specific illnesses, and design personalized treatment regimens. Bioinformatics is integral to this process, providing the computational power to analyze and interpret the genetic variations and molecular patterns that influence health and disease. The resulting insights enable healthcare providers to make more informed decisions, offer targeted therapies, and improve patient outcomes, thereby driving the demand for sophisticated bioinformatics solutions in clinical settings.

Data analytics growth

The growth of data analytics in bioinformatics is transformative, offering powerful tools to decipher the complex data generated by genomic sequencing, gene expression studies, and other omic technologies. Bioinformatics is increasingly focusing on integrating data from multiple omics levels such as genomics, transcriptomics, proteomics, and metabolomics that provides a more comprehensive understanding of biological systems and disease mechanisms. Moreover, data analytics in bioinformatics heavily relies on machine learning (ML) and artificial intelligence (AI) techniques for predictive modeling, pattern recognition, and data interpretation.

Bioinformatics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the product and service, application, and end-use sector.

Breakup by Product and Service:

Knowledge Management Tools

Generalized Knowledge Management Tools

Specialized Knowledge Management Tools

Bioinformatics Platforms

Surgical Simulation Platforms

Sequence Analysis, Alignment and Manipulation Platforms

Structural and Functional Analysis Platforms

Others

Bioinformatics Services

Data Analysis Services

Database Management Services

Others

Bioinformatics platforms dominates the market

The report has provided a detailed breakup and analysis of the market based on the product and service. This includes knowledge management tools (generalized knowledge management tools and specialized knowledge management tools), bioinformatics platforms (surgical simulation platforms, sequence analysis, alignment and manipulation platforms, structural and functional analysis platforms, and others), and bioinformatics services (data analysis services, database management services, and others). According to the report, bioinformatics platforms represented the largest segment.

Breakup by Application:

Genomics

Chemoinformatics and Drug Design

Proteomics

Transcriptomics

Metabolomics

Others

Genomics accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes genomics, chemoinformatics and drug design, proteomics, Transcriptomics, metabolomics, and others. According to the report, genomics represented the largest segment.

Breakup by End-Use Sector:

Medical Biotechnology

Academics

Animal Biotechnology

Agricultural Biotechnology

Environmental Biotechnology

Forensic Biotechnology

Others

Medical biotechnology accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the end-use sector. This includes medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. According to the report, medical biotechnology represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest Bioinformatics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others);Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

ABM Industries

Agilent Technologies

Biomax Informatics

Data4Cure Inc.

Dnastar Inc.

Illumina Inc.

Life Technologies

PerkinElmer Inc.

Qiagen N.V.

Quest Diagnostics

Sophia Genetics SA

Thermo Fisher Scientific Inc.

Waters Corp

WuXi Nextcode Genomics

Key Questions Answered in This Report

  • 1. What is the global bioinformatics market growth?
  • 2. What are the global bioinformatics market drivers?
  • 3. What are the key industry trends in the global bioinformatics market?
  • 4. What is the impact of COVID-19 on the global bioinformatics market?
  • 5. What is the global bioinformatics market breakup by product and service?
  • 6. What are the major regions in the global bioinformatics market?
  • 7. Who are the key companies/players in the global bioinformatics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioinformatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Knowledge Management Tools
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Generalized Knowledge Management Tools
      • 6.1.2.2 Specialized Knowledge Management Tools
    • 6.1.3 Market Forecast
  • 6.2 Bioinformatics Platforms
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Surgical Simulation Platforms
      • 6.2.2.2 Sequence Analysis, Alignment and Manipulation Platforms
      • 6.2.2.3 Structural and Functional Analysis Platforms
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Bioinformatics Services
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Data Analysis Services
      • 6.3.2.2 Database Management Services
      • 6.3.2.3 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemoinformatics and Drug Design
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Proteomics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Transcriptomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Metabolomics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Other Applications
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-Use Sector

  • 8.1 Medical Biotechnology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Animal Biotechnology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Agricultural Biotechnology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Environmental Biotechnology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Forensic Biotechnology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 ABM Industries
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Agilent Technologies
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Biomax Informatics
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Data4cure Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Dnastar Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Life Technologies
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Qiagen N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Quest Diagnostics
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sophia Genetics SA
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis
    • 13.3.14 WuXi Nextcode Genomics
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio